The store will not work correctly when cookies are disabled.
2-Chloro-9-((4-methoxypyridin-2-yl)methyl)-9H-purin-6-amine
ID: ALA4750412
PubChem CID: 162651481
Max Phase: Preclinical
Molecular Formula: C12H11ClN6O
Molecular Weight: 290.71
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccnc(Cn2cnc3c(N)nc(Cl)nc32)c1
Standard InChI: InChI=1S/C12H11ClN6O/c1-20-8-2-3-15-7(4-8)5-19-6-16-9-10(14)17-12(13)18-11(9)19/h2-4,6H,5H2,1H3,(H2,14,17,18)
Standard InChI Key: JDWDPJBXOVOYKJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
11.5286 -5.9954 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.0137 -6.6520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5427 -7.3178 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.7620 -7.0697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0586 -7.4839 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.3481 -7.0850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3368 -6.2679 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.0444 -5.8496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7549 -6.2525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0372 -5.0324 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.7998 -8.0915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6005 -8.2553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1440 -7.6414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9447 -7.8052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2018 -8.5789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6624 -9.1929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8617 -9.0290 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.4842 -7.1913 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.2848 -7.3551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6405 -7.4992 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
1 9 1 0
4 9 1 0
8 10 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
12 17 2 0
18 19 1 0
14 18 1 0
11 12 1 0
3 11 1 0
6 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 290.71 | Molecular Weight (Monoisotopic): 290.0683 | AlogP: 1.51 | #Rotatable Bonds: 3 |
Polar Surface Area: 91.74 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 6.29 | CX LogP: 1.03 | CX LogD: 1.00 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.74 | Np Likeness Score: -0.92 |
References
1. Huang Y,Wu XN,Zhou Q,Wu Y,Zheng D,Li Z,Guo L,Luo HB. (2020) Rational Design of 2-Chloroadenine Derivatives as Highly Selective Phosphodiesterase 8A Inhibitors., 63 (24): [PMID:33291877] [10.1021/acs.jmedchem.0c01573] |